https://www.zacks.com/stock/news/2278180/earnings-estimates-moving-higher-for-krystal-biotech-krys-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2278180
May 23, 2024 - Krystal Biotech (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:2568947542164130085
0
https://www.zacks.com/stock/news/2277954/ke-holdings-inc-sponsored-adr-beke-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2277954
May 23, 2024 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
zc:3121221326012491042
0
https://www.zacks.com/stock/news/2277817/ai-boom-bolsters-nvidia-s-q1-growth-etfs-to-tap?cid=CS-ZC-FT-etf_news_and_commentary-2277817
May 23, 2024 - NVIDIA shares jumped as much as 7.8% in after-market trading on blowout results and surpassed the $1,000 level for the first time ever. Investors can tap the robust growth with the help of ETFs having the largest allocation to NVIDIA.
zc:-5688592506593665933
0
https://www.cnbc.com/2024/05/22/great-wealth-transfer-ai-analyst-sees-a-rosy-time-ahead-for-stocks.html
May 22, 2024 - Financial analyst Tom Lee sees a rosy time ahead for stocks, thanks to the innovation of artificial intelligence and a massive incoming wealth transfer.
0
cnbc:-1001248045878767548
0
https://www.zacks.com/stock/news/2277547/intuit-earnings-buy-this-surging-tech-stock-now-and-hold?cid=CS-ZC-FT-stocks_in_the_news|earnings_preview-2277547
May 22, 2024 - The tax and financial software powerhouse looks poised to finally break out to new all-time highs if Intuit impresses Wall Street when it reports its Q3 FY24 results after the closing bell on Thursday, May 23.
zc:7942626259464186225
0
https://www.zacks.com/stock/news/2277543/lilly-lly-hits-record-high-on-crohn-s-disease-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2277543
May 22, 2024 - Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
zc:-874231685565838484
0
https://www.zacks.com/stock/news/2277493/earnings-estimates-moving-higher-for-century-cenx-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2277493
May 22, 2024 - Century (CENX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:-5115435020872814739
0
https://www.zacks.com/stock/news/2277267/knife-river-knf-forms-hammer-chart-pattern-time-for-bottom-fishing?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2277267
May 22, 2024 - After losing some value lately, a hammer chart pattern has been formed for Knife River (KNF), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
zc:5184492300008023376
0
https://www.zacks.com/stock/news/2277155/stock-market-news-for-may-22-2024?cid=CS-ZC-FT-market_news-2277155
May 22, 2024 - U.S. stocks closed higher on Tuesday, with the S&P 500 and Nasdaq recording new all-time closing highs as investors weighed comments from Federal Reserve officials and looked forward to earnings from NVIDIA on Wednesday afternoon.
zc:-2644526935098120378
0